Shiseido Acquires Breakthrough Technology from Olivo Laboratories
2018年1月12日 - 8:40AM
ビジネスワイヤ(英語)
―Innovative “Second Skin” Technology Brings New
Possibilities to Beauty―
Shiseido Company, Limited (TOKYO:4911) (“Shiseido”), a leading
global cosmetics company, announced today that its regional
headquarters and consolidated subsidiary, Shiseido Americas
Corporation (“Shiseido Americas”), has acquired substantially all
of the assets of Olivo Laboratories, LLC (“Olivo”). Olivo is a
Polaris Partners-backed Massachusetts-based startup advancing the
dermatological field through proprietary biomaterials technology,
including its pioneering XPLTM* “Second Skin” technology. The CEO
is Polaris Partner Amy Schulman. Terms of the transaction were not
disclosed.*Cross-linking Polymer Layer
Olivo’s patented approach creates a breathable, flexible and
nearly invisible artificial skin, that offers a number of
benefits previously unachievable through traditional cosmetics
or even cosmetic surgery. Olivo was founded by renowned scientists
including Dr. Robert Langer*, David H. Koch Institute Professor at
Massachusetts Institute of Technology, Dr. Rox Anderson, Head of
the Wellman Center of Photomedicine at Massachusetts General
Hospital, and Dr. Dan Anderson, Associate Professor of Chemical
Engineering at Massachusetts Institute of Technology. The Olivo
research and development team will join the Shiseido Americas
organization as part of the transaction.* Dr. Langer received more
than 220 awards including the Charles Stark Draper Prize, United
States National Medal of Science, Queen Elizabeth Prize for
Engineering and the 2014 Kyoto Prize.
This acquisition is the latest in a series of initiatives
supported by Shiseido and its Global Innovation Center to further
expand its global beauty innovation footprint. Combining Olivo's
innovative technology with Shiseido’s research and development
capabilities marks a significant leap forward in the emerging realm
of "skin shape correction,” and paves the way for the development
of products that provide instant and significantly enhanced
skincare and suncare.
Masahiko Uotani, President and CEO of Shiseido, said, “Our
transaction with Olivo is an exciting next step in our ongoing
pursuit to create entirely new categories of beauty products at a
global scale as a part of our VISION 2020, middle to long term
strategy. Olivo’s ground-breaking ‘Second Skin’ technology will
join Shiseido’s already robust innovation portfolio, which includes
the personalization technology startup MATCHCo, the artificial
intelligence-empowered beauty company Giaran, and our own
Shiseido-developed OPTUNE, a digital, personalized skincare
platform. We look forward to welcoming our new colleagues at Olivo
and benefiting from the expertise of Dr. Langer as we continue to
reinvent the beauty industry and to create new products tailored to
each of our customers’ unique and personal ideals of beauty.”
Dr. Robert Langer, Co-Founder of Olivo, stated, “We use science
to break down and tackle problems. Here, we were able to really
solve a pervasive problem and create a platform with novel
biomaterials. Shiseido provides an exciting opportunity to continue
executing on that mission and to further demonstrate the many
capabilities of our XPL platform. We look forward to the future
when we unlock the XPL Second Skin’s full potential across a range
of different applications.”
Amy Schulman, CEO of Olivo, noted that, “We are delighted to
work with Shiseido, a company that has the vision, resources and
talent to be pioneers in beauty science and to create a new
standard for skincare in the beauty industry.”
Marc Rey, President and CEO of Shiseido Americas, added, “As the
evolution of beauty-dedicated technologies continues apace, it
becomes increasingly important for companies like Shiseido Group to
take an external view when it comes to innovation and product
development. By joining forces with leaders in scientific research
like Dr. Langer and the Olivo team, we will continue to meet the
demands of the consumer while offering the very latest advances in
science and beauty.”
About Shiseido Company, LimitedShiseido was founded in
1872 as the first Western-style pharmacy in Japan. The business
gradually evolved into a cosmetics company, offering people the
most advanced technology and the finest aesthetics available in the
East or the West. Now, known globally as the premier cosmetics
company with roots in Japan the name Shiseido has come to represent
the world’s highest standard of quality in beauty. Shiseido’s
global selection of skincare, makeup and fragrance includes a
high-performance category for special skincare, and a brightening
line. Shiseido offers products for professional beauty salons and
hairdressers, as well as body care, suncare and a skincare line for
men. Fiercely contemporary and innovative with over 140 years in
business, the Shiseido group brands are now sold in over 120
countries. For more information, please visit
http://group.shiseido.com/.
About Olivo Laboratories, LLCOlivo Laboratories was
founded to answer the unmet needs in the dermatological field,
providing solutions for skin-related medical conditions, through
the development of proprietary biomaterials technologies. Spun out
of “Living Proof” in 2015, the company seeks to create benchmark
solutions through perfectly engineered products that focus on the
skin’s medical and cosmetic problems.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180111005482/en/
Media ContactsFor Shiseido HeadquartersTatsuyoshi
EndoGlobal Communications
Departmenttatsuyoshi.endo@to.shiseido.co.jporFor Shiseido
Americas:Jadzia Zielinski Tirsch, 212-805-2357SVP, Corporate
Communicationsjtirsch@sac.shiseido.comorFor Olivo
Laboratories:Hallie KuhnBusiness
Developmenthallie@olivolabs.com